A New Concept in the Topical Treatment of Onychomycosis With Cyanoacrylate, Undecylenic Acid, and Hydroquinone

Foot & Ankle Specialist

Volumn 1, Issue 2, 2008, Pages 93-96

  Rehder, Paul ^a   Nguyen, Tim T ^a  

^a Oxnard ^*

Author keywords

cyanoacrylate; hydroquinone; nail fungus; onychomycosis; undecylenic acid

Indexed keywords

10 UNDECENOIC ACID; ANTIFUNGAL AGENT; CYANOACRYLATE DERIVATIVE; HYDROQUINONE; HYDROQUINONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; DEBRIDEMENT; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; ONYCHOMYCOSIS; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; CYANOACRYLATES; DEBRIDEMENT; DRUG THERAPY, COMBINATION; FEMALE; FOOT DERMATOSES; HUMANS; HYDROQUINONES; MALE; MIDDLE AGED; ONYCHOMYCOSIS; TREATMENT OUTCOME; UNDECYLENIC ACIDS; YOUNG ADULT;

EID: 77449150392     PISSN: 19386400     EISSN: None     Source Type: Journal    
DOI: 10.1177/1938640008315350     Document Type: Article

References (10)

1. Gupta AK, Fleckman P., Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol. 2000; 43: S70-S80.
2. Warshaw EM, Fett DD, Bloomfield HE, et al. Pulse versus continous terbinafine for onychomycosis: a randomized, double-blind control trial. J Am Acad Dermatol. 2005; 53: 578-584.
3. Baran R., Hay R., Haneke E., Tosti A. Onychomycosis: The Current Approach to Diagnosis and Therapy. 2nd ed. London, England: Taylor & Francis; 2006.
4. Fisher AA Contact Dermatitis. 3rd ed. Philadelphia: Lea & Febiger; 1986.5. Crissey JT, Lang H., Parish LC Manual of Medical Mycology. Cambridge, MA: Blackwell Science; 1995.
5. Mark HF, Bikales NM Encyclopedia of Polymer Science and Engineering. 2nd ed., vols 1-2. New York, NY: Wiley; 1985.
6. Gupta AK Evaluating ciclopirox nail lacquer, oral antifungal agents, and other measures in the management of onychomycosis. Cutis. 2004; 74: 1S, 4.
7. Gupta AK, Lynch L. Management of onychomycosis: examining the role of mono-therapy and dual, triple, or quadruple therapies. Cutis. 2004;74: 1S, 5.
8. Ghannoun MA, Hajjeh RA, Scher R., et al. A large scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution and antifungal susceptibility patterns. J Am Acad Dermatol. 2004; 43: 641-648.
9. Gupta AK, Gover MD, Nouri K., et al. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006; 55: 1048-1071.
10. Finch JJ, Warshaw EM Toenail onychomycosis: current and future treatment options. Dermatol Ther. 2007; 20: 31-46.